References of "Annemans, Lieven"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailAdvantages, disadvantages and feasibility of Pay-for-Quality programs in Belgium
Van Herck, Pieter; Sermeus, Walter; Annemans, Lieven et al

in BMC Health Services Research (2010, October), 10

Detailed reference viewed: 10 (3 ULg)
See detailAvantages, désavantages et faisabilité de l’introduction de programmes “P4Q” en Belgique
Annemans, Lieven; Boeckxstaens, Pauline; Borgermans, Liesbeth et al

Report (2009)

This study is a logical follow up of previous KCE reports about quality of care, namely report 41 about clinical quality indicators in hospitals and report 76 about quality promotion in general practice ... [more ▼]

This study is a logical follow up of previous KCE reports about quality of care, namely report 41 about clinical quality indicators in hospitals and report 76 about quality promotion in general practice. Pay for Performance (P4P) or Pay for Quality initiatives (P4Q), who concentrate exclusively on the quality constituent of performance, establishes a direct correlation between the payment and the outcomes, assessed by structure, process and\or outcome indicators). P4Q initiative arouses an increasing interest, abroad as in our own country. However, the future Belgian initiatives will be able to reach their objective if they are based on what can be learned from experiences led abroad and on a theoretical frame fitting to the Belgian context. Accordingly, the present report will answer the following research questions: 1. What can be learned from the international P4Q models about: • Assessment: what are the benefits and the unintended consequences of the P4Q programs? • The concept and the implementation: which theoretical framework can be applied to the Belgian health care system; how should be conceived the financial incentives; what are the determining success factors? 2. What are the essential conditions required to apply the international P4Q models or add a P4Q constituent to the Belgian quality experiences? • What are the current initiatives in Belgium? Are there proofs of their impact on quality of care? • To what extent are financial planning, databases and other current tools (recommendations of good practice, quality indicators) adequate to implement a P4Q program in the Belgian context of health care? What are the determining factors for success or failure in the implementation of these programs? [less ▲]

Detailed reference viewed: 120 (16 ULg)
Full Text
Peer Reviewed
See detailReal-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma
Annemans, Lieven; Caekelbergh, Karin; Roelandts, Rik et al

in European Journal of Dermatology (2008), 18

Photodynamic therapy with methyl aminolevulinate (MAL-PDT) is a non-invasive therapy for superficial and nodular basal cell carcinoma (BCC). We performed an open-label trial to evaluate efficacy, safety ... [more ▼]

Photodynamic therapy with methyl aminolevulinate (MAL-PDT) is a non-invasive therapy for superficial and nodular basal cell carcinoma (BCC). We performed an open-label trial to evaluate efficacy, safety, tolerability and cosmetic outcome of MAL-PDT in selected patients with superficial and nodular BCCs. Ninety-four superficial and 24 nodular BCCs in 69 patients were treated with 2 to 8 MAL-PDT sessions. Efficacy, safety, tolerability and cosmetic outcome were evaluated at months 1, 3, 6 and 12 after the last MAL-PDT treatment and then every 3 months. One patient discontinued the study for reasons unrelated to study procedures. Complete clinical regression was detected in 84/94 (89.4%) superficial BCCs, and 12/23 (52.2%) nodular BCCs one month after 2 MAL-PDT sessions. No further clinical improvement was observed in either superficial or nodular BCCs with treatment continuation up to a maximum of 8 MAL-PDT sessions. Adverse effects were limited to mild local skin reactions, and cosmetic outcome was rated as excellent or good. Recurrence was observed in 2/84 (2.4%) successfully treated superficial BCCs at 6 and 12 months after treatment discontinuation. Based on the efficacy, tolerability, cosmetic outcome and recurrence rate, our results support the use of MAL-PDT for treatment of superficial BCC and for selected cases of nodular BCC. [less ▲]

Detailed reference viewed: 87 (7 ULg)